MCIM
IPXL

Meadow Creek Investment Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Meadow Creek Investment Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-10,724
Closed -$209K – 1367
2018
Q1 		$209K Buy
10,724
+168
+2% +$3.3K ﹤0.01% 979
2017
Q4 		$176K Buy
10,556
+2,324
+28% +$42.6K ﹤0.01% 1038
2017
Q3 		$167K Buy
8,232
+644
+8% +$12.3K ﹤0.01% 984
2017
Q2 		$122K Buy
7,588
+3,472
+84% +$51.3K ﹤0.01% 1037
2017
Q1 		$52K Buy
4,116
+700
+20% +$8.46K ﹤0.01% 1152
2016
Q4 		$45K Buy
+3,416
New +$58.4K ﹤0.01% 1156

Meadow Creek Investment Management's IPXL Position: Q2 2018 in Review

Meadow Creek Investment Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 10,724 shares — an estimated $209K sold.

Meadow Creek Investment Management first reported a position in IPXL in Q4 2016 and held it in 6 quarters. The position peaked at $209K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • Meadow Creek Investment Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • Meadow Creek Investment Management sold 10,724 Impax Laboratories, Inc. shares in Q2 2018, an estimated $209K.
  • Meadow Creek Investment Management first reported a position in Impax Laboratories, Inc. in Q4 2016 and held it in 6 quarters.
  • Meadow Creek Investment Management's Impax Laboratories, Inc. position peaked at $209K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Meadow Creek Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.